FindTrial
Sign In

Pulmonary disease modeling and drug discoverly using iPS cell.

Pulmonary disease modeling and drug discoverly using iPS cell. - iPS cell technology for pulmonaly diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000020190
Enrollment
5
Registered
2015-12-14
Start date
2015-11-16
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary diseases

Interventions

None listed

Sponsors

Dokkyo Medical University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: pulmonary diseases

Exclusion criteria

Exclusion criteria: agreement of the study

Design outcomes

Primary

MeasureTime frame
To be elucidated the pathogenesis of pulmonary diseases, and be developped drugs using iPS cell technology.—

Countries

Japan

Contacts

Public ContactYasuo Shimizu

Dokkyo Medical University School of Medicine Department of Pulmonary Medicine and Clinical Immunology

yasuo-s@dokkyomed.ac.jp0282861111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026